COCA Call On Zika & Pregnancy - Aug 9

[niman]

Updated Interim Zika Clinical Guidance for Pregnant Women and Data on Contraceptive Use to Decrease Zika-affected Pregnancies

[niman]

Date: Tuesday, August 9, 2016 Time:  2:00 - 3:00 pm (Eastern Time) Join by Phone: 888-942-9686 (U.S. Callers) 517-308-9076 (International Callers) Passcode: 4687942 Join by Webinar The recordings (audio, slides, and transcript) for this call will be posted on the webpage a few days after the COCA Call.     Follow these steps to earn free continuing education.               Presenters:    Charlan D. Kroelinger, PhD, MA Team Lead Division of Reproductive Health National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention Erin Berry-Bibee, MD, MPH Guest Researcher / Assistant Professor Division of Reproductive Health Centers for Disease Control and Prevention Department of Obstetrics and Gynecology University of North Carolina Chapel Hill Titilope Oduyebo, MD, MPH Medical Officer Division of Reproductive Health National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention   Accreditation Statements:   CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians. The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 1.0 contact hour. IACET CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU's for this program. CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614. ACPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-16-167-L04-P and enduring 0387-0000-16-167-H04-P course category. Course Category: This activity has been designated as knowledge-based. Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor. AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at [email protected] if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession. CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program. CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.org. There is no cost for this program. Return to Top ⇧   The Emergency Risk Communication Branch in the Division of Emergency Operations, Office of Public Health Preparedness and Response is responsible for the management of all COCA products.   For information about this update or other clinical issues, or to send your feedback, please contact us at[email protected] CDC Clinician Outreach and Communication Activity Facebook page – connect with COCA on Facebook Clinician Outreach and Communication Activity – resources for health care providers COCA RSS Feed – subscribe to be notified of conference calls, updates, and CDC guidance for health providers Crisis & Emergency Risk Communication Training – training program that draws from lessons learned during public health emergencies, and incorporates best practices from the fields of risk and crisis communication   Health Alert Network – CDC's primary method of sharing cleared information about urgent public health incidents with public information officers; federal, state, territorial, and local public health practitioners; clinicians; and public health laboratories CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. Links to non-federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of the individual organizations.

[niman]

Overview: CDC’s top priority for the Zika response is to protect pregnant women and their fetuses from the adverse effects of Zika virus infection in pregnancy. As a result, CDC continues to evaluate all available evidence and update recommendations as new information becomes available. CDC has updated its interim guidance for U.S. healthcare providers caring for pregnant women with possible Zika virus exposure based on emerging evidence about laboratory testing for the diagnosis of Zika. A primary strategy to reduce Zika-related pregnancy complications is to prevent pregnancy among women who want to delay or avoid pregnancy. CDC published contraceptive use data for states where mosquito-borne transmission of Zika is possible. During this COCA Call, clinicians will learn about the updated CDC interim guidance for caring for pregnant women with possible Zika virus exposure, and strategies for increasing access to contraceptive methods and services to minimize the number of pregnancies affected by Zika.

[niman]

Objectives • Discuss revised diagnostic testing for Zika virus infection among pregnant women. • Discuss clinical management of pregnant women with confirmed or possible Zika virus infection. • Review use of a range of contraceptive methods in states, with a focus on highly effective methods. • Define strategies for increasing access and availability to highly effective contraception.